Over 8 years BioBusiness has brought together over 2500 business development professionals and CEOs from pharma and biotech as well as key healthcare investors. BioBusiness 2009 showcased deals and experts from leading pharma such as GLAXOSMITHKLINE, MERCK, BAYER SCHERING, PFIZER and ASTELLAS. With generics threatening pipelines and M&A at every scale high on industry agendas, delegates left with the contacts they needed to ensure essential business relationships and deals which will deliver success in 2009. With a speaker faculty reading like a whos who of pharma partnering, BioBusiness 2010 is consolidating its place as the most senior-level and effective partnering event in Europe. As the recession bites, both pharma and biotech are having to make tough choices about the events which will yield the best results for their organizations. Thats why weve made BioBusiness and easy choice for you.